Oak Grove Capital LLC - NEUBASE THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

NEUBASE THERAPEUTICS INC's ticker is NBSE and the CUSIP is 64132K102. A total of 53 filers reported holding NEUBASE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Oak Grove Capital LLC ownership history of NEUBASE THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$134,000
-11.8%
19,175
-4.0%
0.04%
-38.9%
Q3 2020$152,000
-38.2%
19,975
-28.6%
0.07%
-51.4%
Q2 2020$246,000–27,975–0.15%–
 Download
Other shareholders
NEUBASE THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
CARNEGIE MELLON UNIVERSITY 46,970$40,8550.05%
View complete list of NEUBASE THERAPEUTICS INC shareholders